2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On August 27, 2026, Digi International entered into an amended and restated $350 million senior secured revolving credit agreement with BMO Bank N.A. as administrative agent. The new facility replaces a $250 million agreement dated December 7, 2023, which Digi paid off and terminated, and it matures on August 27, 2031. The company says the expanded capacity and lower pricing give it more financial flexibility for acquisitions, though the filing does not report any earnings or cash flow figures.
$350 million senior secured revolving facility, with an uncommitted accordion of the greater of $130 million or 100% of trailing four-quarter EBITDA, maturing August 27, 2031.
Replaces the $250 million revolving credit agreement dated December 7, 2023, which was paid off and terminated on August 27, 2026.
Term SOFR margins range from 1.25% to 2.625%, compared with 135 to 310 basis points under the prior facility, according to the press release.
Maximum total net leverage covenant increased from 3.0x to 3.50x; minimum interest coverage ratio of 3.00x is unchanged.
Americold closed its joint venture with EQT's Active Core Infrastructure fund on August 31, 2026, contributing 12 cold storage facilities valued at more than $1.3 billion. Americold received approximately $1.1 billion in net cash proceeds, which it intends to use to repay outstanding debt, and it will hold a 30% stake and serve as day-to-day manager. Shareholders face a capped contingent income support obligation of up to $70 million over the term.
Joint venture closed August 31, 2026; EQT holds 70% and Americold holds 30% of Americold-EQT Cold Storage Partnership, LLC
Approximately $1.1 billion in net cash proceeds, expected to be used to repay outstanding indebtedness
Income support arrangement capped at up to $70 million over the 10-year term
Joint venture obtained mortgage financing of up to $863.5 million, of which $845.5 million was drawn at closing
Array Technologies said it completed its acquisition of Affordable Wire Management, LLC (AWM), a provider of wire management and balance-of-system products for solar and energy storage projects, on August 31, 2026. Buyer paid cash consideration of approximately $165 million, net of customary adjustments and subject to final post-closing settlement. The company expects the deal to be at least high single digit accretive to Adjusted EPS in the first year before synergies.
Acquisition of AWM completed August 31, 2026 under a purchase agreement dated July 16, 2026
Cash consideration of approximately $165 million, subject to final post-closing settlement
Expected to be at least high single digit accretive to Adjusted EPS in the first year before synergies
Kevin G. Hostetler is CEO of Array; Scott Rand and Dan Smith, AWM co-founders, join as leaders of the combined business
PMV Pharmaceuticals reported updated interim ovarian cancer data for rezatapopt from the Phase 2 pivotal portion of its PYNNACLE trial, with a 46% overall response rate among 76 evaluable patients. The company said recent FDA feedback supports submitting a new drug application for accelerated approval in platinum-resistant or refractory ovarian cancer in the first quarter of 2027, which sets a timeline for shareholders to track.
Overall response rate of 46% (35 of 76 patients) as of a May 14, 2026 data cutoff; median duration of response was 10.0 months
Company anticipates submitting an NDA for accelerated approval in the first quarter of 2027
Discontinuation due to treatment-related adverse events was 5%; full update on all Phase 2 cohorts planned for the fourth quarter of 2026 at a medical conference
BOK Financial filed an August 2026 investor presentation furnished under Regulation FD, which includes second-quarter 2026 results and an updated full-year 2026 outlook dated 07/21/26. Net income and diluted earnings per share rose from the prior quarter and the prior year, and the company reported no provision for credit losses in the quarter.
Q2 2026 net income was $176.5 million, or $2.92 per diluted share, versus $155.8 million, or $2.58, in Q1 2026 and $140.0 million, or $2.19, in Q2 2025.
Period-end loans grew $896 million, or 3.4% sequentially, to $27.1 billion; net charge-offs were $500 thousand.
The 2026 outlook as of 07/21/26 projects net interest income of $1.42 to $1.45 billion and fees and commissions of $820 to $845 million.
The company expects a 2026 efficiency ratio of about 62%, compared with 65.1% in 2025.
Cadrenal Therapeutics said that at a Type D meeting with the U.S. Food and Drug Administration held July 28, 2026, the company and the FDA aligned on key aspects of the protocol and Statistical Analysis Plan for a Phase 3 registrational study of CAD-1005 in heparin-induced thrombocytopenia (HIT). The filing says the agreement sets the primary endpoint definition and the use of a placebo control, which the company says clarifies the regulatory path, but it does not disclose financial results, costs, or a trial start date.
Type D meeting with the FDA held July 28, 2026; the company announced the feedback on August 31, 2026.
Primary endpoint measures the proportion of Serotonin Release Assay-positive participants with adjudicated new or worsening composite thromboembolic events through Day 14 or hospital discharge.
The FDA agreed to a placebo control, with standard anticoagulation therapeutics in both the CAD-1005 and placebo arms.
The company states that approximately 50,000 patients in the U.S. have acute HIT each year.
Koss Corporation reported fourth-quarter fiscal 2026 net sales of $3,263,853, up 5.8%, and net income of $476,801, compared with a net loss of $232,696 a year earlier. For the full year, sales rose 3.1% to $13,020,773 and the net loss narrowed to $391,464 from $874,831, with $1.0 million of tariff refunds received in the fourth quarter helping gross margin improve to 41.9%. Both headline sales and profit measures improved for shareholders, although the filing gives no forward guidance and European distributor sales declined.
Q4 net sales were $3,263,853, up $179,643 or 5.8% from $3,084,210 a year earlier.
Q4 net income was $476,801, or $0.05 per share, versus a net loss of $232,696, or $0.02 per share, in the prior-year quarter.
Full-year net loss was $391,464, or $0.04 per share, down $483,367 from $874,831, or $0.09 per share, in fiscal 2025.
Full-year gross margin rose to 41.9% from 37.8%, helped by $1.0 million in tariff refunds received in the fourth quarter.
Southland's subsidiaries agreed on August 26, 2026 to pay Liberty Mutual $5 million by September 30, 2026 to resolve about $36.4 million of surety losses tied to the Washington State Convention Center project. Southland expects the settlement to favorably affect pre-tax income by about $29 million in the third quarter of 2026, though that estimate is preliminary and subject to accounting review.
Settlement with Liberty Mutual, Zurich American and Fidelity and Deposit covers about $36.4 million of surety losses, about $34 million of which relates to the WSCC Judgement.
Company will pay $5 million to Liberty on or before September 30, 2026.
Preliminary estimate: favorable impact of about $29 million on income before income taxes in Q3 2026, subject to change.
Negotiations with Zurich to resolve the remaining surety payable related to the WSCC Judgement are ongoing.
SentinelOne reported second-quarter fiscal 2027 revenue of $292 million, up 21% from a year earlier, and said it exceeded its guidance. The company raised its fiscal 2027 revenue and non-GAAP operating income outlook, but it still reported a GAAP net loss of $93.4 million for the quarter.
Q2 revenue was $292 million, up from $242 million; annualized recurring revenue (ARR) grew 22% to $1.218 billion as of July 31, 2026.
Fiscal 2027 revenue guidance is now $1.202 billion to $1.207 billion; non-GAAP operating income guidance is $124 million to $128 million.
GAAP net loss was $93.4 million, or $(0.27) per share, versus $(0.22) a year earlier; non-GAAP diluted EPS was $0.08, versus $0.04.
Cash, cash equivalents and investments totaled $813 million as of July 31, 2026.
Ulta Beauty reported second-quarter fiscal 2026 results with net sales up 8.9% to $3.0 billion and diluted EPS up 13.3% to $6.55. The company raised its fiscal 2026 diluted EPS outlook to $28.70 to $29.00 from $28.36 to $28.80 and increased its fiscal 2026 stock repurchase plan to $1.8 billion from $1.5 billion, which matters to shareholders because it signals stronger expected profit and more capital returned to them.
Net sales rose 8.9% to $3.0 billion, while comparable sales increased 3.8% for the quarter ended August 1, 2026.
Operating income increased 10.1% to $379.6 million; gross margin slipped to 39.1% from 39.2%.
Updated fiscal 2026 diluted EPS outlook is $28.70 to $29.00, up from $28.36 to $28.80.
Fiscal 2026 repurchase plan increased to $1.8 billion from $1.5 billion; $1.0 billion remained under the $3.0 billion program as of August 1, 2026.
Elastic reported first-quarter fiscal 2027 results for the quarter ended July 31, 2026, with total revenue of $478 million, up 15% year over year. GAAP net loss narrowed to $16.7 million from $24.6 million a year earlier, and non-GAAP diluted earnings per share rose to $0.70 from $0.60. The company also issued guidance for the second quarter and full fiscal 2027, with fiscal 2027 revenue expected between $1.998 billion and $2.010 billion.
Total revenue of $478 million, up 15% year over year; sales-led subscription revenue of $399 million, up 18%
GAAP net loss of $16.7 million versus $24.6 million a year earlier, including a $19.9 million restructuring and other related charge
Non-GAAP diluted earnings per share of $0.70 versus $0.60 a year earlier
Q2 fiscal 2027 revenue guidance of $486 million to $487 million; fiscal 2027 revenue guidance of $1.998 billion to $2.010 billion
Rubrik reported second-quarter fiscal 2027 revenue of $427.3 million, up 38% from a year earlier, and a GAAP net loss of $(0.30) per share, narrower than $(0.49) a year earlier. The company raised guidance for all guided metrics for fiscal 2027 and said results exceeded all guided metrics. The board also added Rakefet Russak-Aminoach as a director, expanding the board from eight to nine members.
Q2 total revenue $427.3 million, up 38% from $309.9 million; subscription ARR $1.66 billion, up 33% year over year
GAAP net loss per share $(0.30) vs $(0.49); non-GAAP diluted net income per share $0.20 vs $(0.03)
Fiscal 2027 revenue guidance $1,685 million to $1,693 million; free cash flow guidance $323 million to $333 million
Rakefet Russak-Aminoach appointed Class I director effective August 26, 2026, with a term expiring at the 2028 annual meeting
Marvell reported record second-quarter fiscal 2027 net revenue of $2.739 billion, up 37% from a year earlier and $39.0 million above the midpoint of its May 27, 2026 guidance. GAAP net income was $308.0 million, or $0.33 per diluted share, compared with $194.8 million, or $0.22, a year earlier. The company said it is again raising its revenue outlook for fiscal 2027 and fiscal 2028, and it expects third-quarter revenue of $3.150 billion, plus or minus 5%.
Data center revenue was $2.171 billion, up 46% year over year, while communications and other revenue was $567.8 million, up 10%.
Q2 non-GAAP diluted EPS was $0.94, compared with $0.67 a year earlier; GAAP diluted EPS was $0.33.
Third-quarter outlook: net revenue of $3.150 billion plus or minus 5%, and non-GAAP diluted EPS of $1.10 plus or minus $0.05.
Marvell will hold an Investor Day on October 6, 2026.
Autodesk reported second-quarter fiscal 2027 revenue of $2.05 billion, up 16% year over year, and GAAP diluted earnings per share of $2.33 versus $1.46 a year earlier. The company raised its fiscal 2027 billings and revenue growth guidance, citing higher underlying growth expectations and the contribution from the MaintainX acquisition, while keeping its non-GAAP operating margin guidance unchanged.
Q2 revenue of $2,046 million, up 16% (14% in constant currency); billings of $1,854 million, up 10%
GAAP diluted EPS of $2.33 versus $1.46 a year earlier; non-GAAP EPS of $3.30, up $0.68 year over year
FY27 revenue guidance of $8,295 million to $8,345 million; non-GAAP operating margin guidance unchanged at about 39%
FY27 free cash flow guidance narrowed to $2,725 million to $2,750 million, including about $45 million of MaintainX transaction expenses
Workday reported fiscal 2027 second-quarter total revenues of $2.649 billion, up 12.8% year over year, and non-GAAP diluted earnings per share of $2.75, up from $2.21. The company raised its fiscal 2027 non-GAAP operating margin guidance to 31.0% and authorized an open-ended repurchase of up to $4.0 billion of Class A common stock.
Total revenues of $2.649 billion, up 12.8%; subscription revenues of $2.471 billion, up 13.9%
GAAP diluted net income per share of $2.57 includes a $1.52 per share tax benefit tied to an intellectual property transfer; non-GAAP figure was $2.75
Fiscal 2027 subscription revenue guidance of $9.940 billion to $9.950 billion; non-GAAP operating margin guidance raised to 31.0%
Operating cash flow was $520 million versus $616 million a year earlier; free cash flow was $460 million versus $588 million
Vince Holding's subsidiary completed the acquisition of the operating business of October's Very Own (OVO), a Canadian streetwear lifestyle brand, on August 24, 2026, while Authentic Brands Group took majority ownership of OVO's intellectual property. The company will hold a 5% stake in the OVO IP for $6,000,000 and a license to use it, with royalties payable to Authentic, and says the deal is expected to be earnings neutral in fiscal 2026 and accretive in fiscal 2027. The company also expects second quarter fiscal 2026 results at the high end of its prior guidance, excluding any tariff refund benefit.
OVO operating business acquired; the purchase agreement closed on August 24, 2026
Company to own 5% of OVO IP for $6,000,000 and hold a license with an initial term ending at the end of fiscal 2036
Q2 fiscal 2026 results expected at the high end of prior guidance, excluding any benefit from tariff refunds
Full second quarter results to be reported by September 15, 2026
HealthEquity reported second-quarter results for the period ended July 31, 2026, with revenue up 8%, net income up 10% and GAAP diluted earnings per share of $0.78, compared with $0.68 a year earlier. The company also raised its fiscal 2027 guidance, now expecting revenue of $1.411 billion to $1.421 billion and GAAP net income of $2.88 to $2.96 per diluted share.
Q2 revenue rose 8% to $350.7 million; net income rose 10% to $65.6 million
Adjusted EBITDA rose 11% to $167.0 million, with margin at 48% versus 46% a year earlier
Fiscal 2027 outlook: revenue $1.411 billion to $1.421 billion; non-GAAP EPS $4.66 to $4.73
Repurchased $108.1 million of stock in the quarter; $948.4 million remained authorized as of July 31, 2026
Best Buy reported second-quarter fiscal 2027 revenue of $9.78 billion, up from $9.44 billion a year earlier, and diluted EPS of $1.48, up from $0.87. The company raised its full-year FY27 adjusted diluted EPS guidance to $6.70 to $6.90 from $6.30 to $6.60, and also announced that Jason Bonfig will succeed Corie Barry as CEO effective November 1, 2026.
Q2 enterprise comparable sales rose 4.1%, with Domestic up 4.5% and International down 1.8%.
Diluted EPS was $1.48 versus $0.87; adjusted diluted EPS was $1.47 versus $1.28.
FY27 revenue guidance raised to $42.3 billion to $42.8 billion from $41.2 billion to $42.1 billion.
Quarterly dividend of $0.96 per share is payable October 8, 2026, to holders of record on September 17, 2026.
Dollar General reported second-quarter fiscal 2026 net sales up 5.2% to $11.3 billion, operating profit up 29.2% to $769.2 million and diluted EPS up 33.3% to $2.48. The company raised its fiscal 2026 diluted EPS guidance to $7.80 to $8.00 from $7.20 to $7.45, including an estimated $0.25 benefit from tariff refunds in the second quarter, and said it expects to resume share repurchases in the second half of the year.
Same-store sales rose 3.5%, with customer traffic up 2.0% and average transaction amount up 1.5%
Fiscal 2026 diluted EPS guidance is $7.80 to $8.00, up from $7.20 to $7.45 previously
Board declared a quarterly dividend of $0.59 per share, payable on or before October 20, 2026, to holders of record on October 6, 2026
Share repurchases of up to $700 million planned for fiscal 2026; $1.4 billion remained under the authorization at the end of the quarter
Burlington Stores reported second-quarter fiscal 2026 total sales up 11% to $3.0 billion and net income of $184 million, or $2.88 per diluted share, versus $94 million, or $1.47, a year earlier. The results include $55 million in tariff refunds, which the company plans to reinvest in lower prices in the second half, and the company raised its full-year Adjusted EPS guidance to $11.77 to $11.97.
Total sales rose 11% to $2,998 million; comparable store sales rose 2%
Net income was $184 million, or $2.88 per diluted share, vs. $94 million, or $1.47, a year earlier
Adjusted EPS was $2.37 excluding tariff refunds and certain bankruptcy acquired lease expenses, up 38% from $1.72
Fiscal 2026 guidance now calls for comparable store sales growth of 3% to 4% and Adjusted EPS of $11.77 to $11.97
Dollar Tree reported fiscal 2026 second-quarter net sales of $4.9 billion, up 7.0%, and diluted EPS of $2.70, compared with $0.75 a year earlier from continuing operations. The company raised its fiscal 2026 adjusted EPS outlook to $7.70 to $8.05, and both figures include tariff refund benefits that the company says are partly reinvested.
Q2 net sales rose 7.0% to $4.9 billion; comparable store net sales rose 3.7%, with traffic up 0.4%.
Q2 diluted EPS was $2.70, including a $1.31 benefit from the net impact of tariff refunds.
Fiscal 2026 adjusted diluted EPS outlook raised to $7.70 to $8.05, including an approximate $0.60 tariff refund benefit.
Q3 fiscal 2026 adjusted EPS outlook is $0.80 to $0.95, including a $0.50 impact from tariff refund reinvestments.
Phibro Animal Health reported results for the fiscal year ended June 30, 2026, with net sales up 17% to $1.52 billion and net income up to $99.7 million from $48.3 million. It also gave fiscal 2027 guidance for net sales of $1.55 billion to $1.60 billion and adjusted diluted EPS of $3.41 to $3.59, and said it will close its Chicago Heights, Illinois plant, affecting about 100 employees.
Fiscal 2026 diluted EPS was $2.43, up $1.24, and adjusted EBITDA was $255.0 million, up 39%.
Fourth-quarter net sales were $396.7 million, up 5%, and net income was $21.7 million, up 26%.
Fiscal 2027 guidance: net income of $122 million to $132 million and adjusted EBITDA of $258 million to $268 million.
Chicago Heights production is expected to cease during the summer of 2027, with products moved to other Phibro facilities and third-party contract manufacturers.
Synopsys reported third-quarter fiscal 2026 revenue of $2.477 billion, up from $1.740 billion a year earlier, and GAAP earnings of $2.84 per diluted share versus $1.50. The company raised its full-year fiscal 2026 revenue and non-GAAP EPS expectations, citing AI-driven demand, which signals stronger expected results for shareholders.
Q3 revenue was $2.477 billion versus $1.740 billion in Q3 fiscal 2025.
Q3 non-GAAP EPS was $3.91 versus $3.39; GAAP EPS was $2.84 versus $1.50.
Full-year fiscal 2026 revenue midpoint raised to $9.715 billion; non-GAAP EPS midpoint raised to $15.07.
Q4 fiscal 2026 non-GAAP EPS target range is $4.10 to $4.16 on revenue of $2.530 billion to $2.580 billion.
NVIDIA reported second-quarter fiscal 2027 revenue of $96.2 billion, up 106% from a year ago, and GAAP diluted earnings per share of $2.46 versus $1.08 a year earlier. It expects third-quarter revenue of $108.0 billion, plus or minus 2%, and returned about $26.0 billion to shareholders during the quarter. Shareholders see strong growth in both sales and profit, though GAAP net income includes $7.8 billion of net gains from equity securities.
Q2 fiscal 2027 revenue of $96.2 billion, up 106% from a year ago and 18% from the prior quarter
GAAP diluted EPS of $2.46 vs. $1.08 a year ago; non-GAAP diluted EPS of $2.22 vs. $1.01
Q3 fiscal 2027 revenue outlook of $108.0 billion, plus or minus 2%, assuming no Data Center compute revenue from China
About $26.0 billion returned to shareholders; $99.0 billion remaining under buyback authorization; $0.25 dividend payable October 1, 2026
HP reported fiscal third-quarter 2026 net revenue of $15.7 billion, up 12.5% from a year earlier, and non-GAAP diluted EPS of $0.83, up 11%. GAAP diluted EPS fell 11% to $0.71 from $0.80, and both figures include an $0.11 benefit from tariff refunds. HP raised its fiscal 2026 non-GAAP EPS and free cash flow outlook, which matters to shareholders because it signals stronger expected full-year profit and cash generation.
Q3 net revenue was $15.7 billion, up 12.5% from $13.9 billion in the prior-year quarter.
Non-GAAP diluted EPS was $0.83, up from $0.75; GAAP diluted EPS was $0.71, down from $0.80.
Fiscal 2026 non-GAAP diluted EPS outlook raised to $3.19 to $3.29; GAAP outlook raised to $2.52 to $2.62.
Fiscal 2026 free cash flow outlook raised to $3.0 to $3.2 billion; Q3 returned $0.6 billion to shareholders.
Ooma reported fiscal second quarter 2027 revenue of $83.2 million, up 25% from a year earlier, with GAAP net income of $3.0 million, or $0.10 per diluted share, versus $1.3 million, or $0.04, a year earlier. The company also issued fiscal 2027 and third-quarter guidance, with full-year revenue expected at $332.0 million to $333.5 million, and said it reduced outstanding debt to $47 million.
Total revenue was $83.2 million, up 25% year over year; subscription and services revenue was $75.6 million, 91% of the total.
GAAP net income was $3.0 million, or $0.10 per diluted share, compared with $1.3 million, or $0.04, in the second quarter of fiscal 2026.
Non-GAAP net income was $10.2 million, or $0.35 per diluted share, up from $6.5 million, or $0.23; Adjusted EBITDA was $12.4 million versus $7.2 million.
Fiscal 2027 guidance: total revenue of $332.0 million to $333.5 million and GAAP net income of $11.9 million to $12.7 million.
Lantronix reported fiscal fourth-quarter 2026 revenue of $31.2 million, up 8% from a year earlier, with non-GAAP EPS of $0.04 and GAAP EPS of ($0.01). Full-year fiscal 2026 revenue was $120.9 million, down from $122.9 million in fiscal 2025, and the company expects double-digit revenue growth in fiscal 2027 and first-quarter fiscal 2027 revenue of $31.0 million to $33.0 million.
Q4 fiscal 2026 revenue of $31.2 million, up 8% year over year; GAAP net loss per share of ($0.01) versus ($0.07) a year earlier
Non-GAAP EPS of $0.04 for the quarter, compared with $0.01 a year earlier
Full-year fiscal 2026 revenue of $120.9 million versus $122.9 million in fiscal 2025; GAAP EPS of ($0.10) versus ($0.29)
Q1 fiscal 2027 outlook: revenue of $31.0 million to $33.0 million and non-GAAP EPS of $0.04 to $0.06
CrowdStrike reported fiscal second-quarter 2027 revenue of $1.47 billion, up 26% from a year earlier, and GAAP net income attributable to CrowdStrike of $5.3 million, compared with a loss of $70.2 million a year earlier. The company raised its fiscal 2027 net new ARR growth guidance to 34% at the midpoint, an increase of 630 basis points, which is a significant change in its outlook for shareholders.
Total revenue was $1.47 billion, up 26% from $1.17 billion in Q2 fiscal 2026; ARR grew 25% to $5.84 billion as of July 31, 2026.
GAAP net income attributable to CrowdStrike was $5.3 million, or $0.01 per diluted share, versus a loss of $70.2 million, or $0.07 per share, a year earlier.
Fiscal 2027 net new ARR growth guidance was raised to 34% at the midpoint, up 630 basis points.
Full-year fiscal 2027 total revenue guidance is $5,991.1 million to $6,011.1 million; Q3 fiscal 2027 total revenue guidance is $1,523.2 million to $1,529.2 million.
Veeva reported second-quarter fiscal 2027 total revenues of $928.0 million, up 18% from a year earlier, with GAAP diluted net income per share of $1.66 versus $1.19. The company said its full-year view improved and issued updated fiscal 2027 guidance, which points to higher revenue and non-GAAP earnings per share for shareholders.
Q2 total revenues $928.0 million, up 18%; subscription revenues $766.8 million, up 16%
GAAP diluted EPS $1.66 vs. $1.19 a year ago; non-GAAP diluted EPS $2.35 vs. $1.99
Fiscal 2027 guidance: total revenues $3,682 million to $3,687 million; non-GAAP diluted EPS of approximately $9.21
Fiscal third-quarter guidance: total revenues $932 million to $935 million; non-GAAP diluted EPS $2.33 to $2.34
Everpure reported fiscal second-quarter 2027 revenue of $1.2 billion, up 38% from a year earlier, and net income of $74 million, up from $47 million. The company raised its fiscal 2027 revenue guidance to $5.03 billion to $5.07 billion from $4.41 billion to $4.51 billion, but operating cash flow was negative $136 million in the quarter.
Q2 fiscal 2027 revenue was $1.2 billion, up 38% year over year; product revenue was $687 million, up 54%.
Net income was $74 million, or $0.21 per diluted share, compared with $47 million, or $0.14, a year earlier.
Fiscal 2027 revenue guidance rose to $5.03 billion to $5.07 billion; non-GAAP operating income guidance rose to $940 million to $960 million.
Operating cash flow was negative $136 million and free cash flow was negative $238 million in the quarter.
Agilent reported third-quarter fiscal 2026 revenue of $1.88 billion for the quarter ended July 31, 2026, up 8.1% from a year earlier, with GAAP EPS of $1.28 versus $1.18. The company raised its fiscal 2026 non-GAAP EPS guidance to $6.18 to $6.21 and its revenue guidance to $7.49 billion to $7.51 billion, so both headline results and forward expectations moved higher for shareholders.
Q3 revenue was $1.88 billion, up 8.1% reported and 7.3% core; GAAP net income was $362 million, or $1.28 per share.
Non-GAAP EPS was $1.62, up 18% from the year-ago quarter, including a $0.06 net benefit from tariff refunds.
Fiscal 2026 non-GAAP EPS is now expected at $6.18 to $6.21, an increase of 15 cents at the midpoint.
Fourth-quarter 2026 revenue is expected at $1.98 billion to $2.0 billion, with non-GAAP EPS of $1.71 to $1.74 and no future tariff refund benefit assumed.
Salesforce reported second-quarter fiscal 2027 revenue of $11.3 billion, up 11% from a year earlier, including a $456 million contribution from Informatica. GAAP diluted net income per share was $4.29, versus $1.96 a year earlier, and included a $2.43 per share gain on strategic investments. The company raised its full-year fiscal 2027 revenue guidance to $46.1 billion to $46.4 billion, a change that includes pending acquisitions of Contentful and Fin.
Q2 FY27 revenue of $11.3 billion, up 11% Y/Y; Informatica contributed $456 million
GAAP diluted net income per share of $4.29 vs. $1.96 a year earlier; non-GAAP diluted EPS of $5.90
Full-year FY27 revenue guidance raised to $46.1 billion to $46.4 billion; the $200 million raise includes pending Contentful and Fin acquisitions
Third-quarter FY27 revenue guidance of $11.42 billion to $11.5 billion; final ASR settlement expected in October 2026
Okta reported fiscal second-quarter 2027 results for the period ended July 31, 2026, with total revenue of $805 million, up 11% year-over-year, and GAAP net income of $116 million, up from $67 million. The company also updated its full-year fiscal 2027 revenue outlook to $3.216 billion to $3.226 billion, representing 10% to 11% growth, and gave third-quarter revenue guidance of $813 million to $817 million.
Q2 total revenue was $805 million, up 11%; subscription revenue was $793 million, up 12%.
GAAP diluted net income per share was $0.65, compared with $0.37 a year earlier; non-GAAP diluted EPS was $1.05, compared with $0.91.
Full-year fiscal 2027 revenue guidance is $3.216 billion to $3.226 billion; the company cites about a one-point headwind from shifting professional services to partners.
Cash cash equivalents and short-term investments were $2.299 billion at July 31, 2026, after $350 million was paid to settle the 2026 notes.
Nutanix reported fourth-quarter fiscal 2026 revenue of $757.1 million, up 16% from a year earlier, and annual recurring revenue of $2.55 billion, also up 16%. GAAP net income of $1.27 billion was driven largely by a $1.19 billion income tax benefit, while non-GAAP operating income rose to $198.0 million from $119.5 million, and the company gave fiscal 2027 revenue guidance of $3.180 billion to $3.230 billion.
Q4 revenue $757.1 million vs. $653.3 million a year earlier; fiscal 2026 revenue $2.85 billion, up 12%
Q4 GAAP diluted EPS $4.34 vs. $0.13 a year earlier, including a $1.19 billion income tax benefit
Q4 non-GAAP operating margin 26.2% vs. 18.3%; free cash flow $277.6 million vs. $207.8 million
Q1 fiscal 2027 revenue outlook $755 million to $765 million; fiscal 2027 free cash flow outlook $850 million to $950 million
Borealis Foods reported preliminary U.S. K-12 school foodservice revenue up 110% for the six months ended June 30, 2026, compared with the same period in 2025. The figure is unaudited and may change when the company completes its financial statements for the quarter, and the filing gives no total company revenue, profit or guidance.
Preliminary K-12 channel revenue rose 110% for the six months ended June 30, 2026, versus the same period in 2025.
The company says it now serves more than 20,000 schools, representing about 2,500 school districts.
School products shipped over the past 12 months through 106 distributors across 40 states.
The revenue figure is unaudited and subject to adjustment before the quarter's financial statements are finalized.
Williams-Sonoma reported second-quarter 2026 net revenues of $1.96 billion, up 6.7% from a year earlier, with comparable brand revenue up 6.2%. GAAP diluted EPS was $2.84 versus $2.00, and non-GAAP diluted EPS was $2.10, up 5%, after excluding tariff refund items, and the company raised its full-year 2026 outlook for net revenues, comparable sales and non-GAAP operating margin.
Q2 net revenues $1,959.8 million vs. $1,836.8 million a year earlier; comparable brand revenue +6.2%
GAAP diluted EPS $2.84 vs. $2.00; non-GAAP diluted EPS $2.10 vs. $2.00, including a $167.8 million tariff refund income reduction to cost of goods sold
Fiscal 2026 outlook raised: net revenues +4.7% to +7.2%, comps +4.0% to +6.5%, non-GAAP operating margin 17.8% to 18.2%
Outlook excludes any benefit from tariff refunds or related interest; quarterly results remain preliminary until the Form 10-Q is filed
Abercrombie & Fitch reported second-quarter fiscal 2026 net sales of $1.3 billion, up 5% from a year earlier, and diluted EPS of $4.17 versus $2.91 a year ago. The quarter includes about $100 million of IEEPA tariff refunds, worth $1.75 per diluted share, and the company raised its full-year EPS outlook to $13.10 to $13.60 from $10.20 to $11.00.
Q2 net sales $1.3 billion, up 5%; comparable sales flat
Operating margin 19.9% vs 17.1% a year ago; includes about $100 million tariff refund benefit
Full-year EPS outlook raised to $13.10 to $13.60; share repurchases at least $500 million vs around $450 million previously
Q3 outlook: net sales growth 5% to 6%, EPS $2.90 to $3.20
Dycom reported record fiscal 2027 second-quarter contract revenue of $2.006 billion, up 45.6% from a year earlier, with net income of $115.6 million, or $3.81 per diluted share, versus $3.33 a year earlier. The company raised its full-year fiscal 2027 contract revenue outlook to $7.48 billion to $7.66 billion, though it also deferred about $150 million of Communications wireless program revenue into fiscal 2028.
Q2 contract revenues were $2.006 billion, up 45.6%, or 16.7% organically, versus the quarter ended July 26, 2025.
Q2 net income was $115.6 million, or $3.81 per diluted share, compared with $97.5 million, or $3.33, a year earlier.
Full-year fiscal 2027 contract revenue outlook is $7.48 billion to $7.66 billion; third-quarter contract revenue is expected at $1.90 billion to $1.98 billion.
The acquisition of National Technology Integrators was completed in the quarter and contributed about $22.9 million of revenue.
J.M. Smucker reported first-quarter fiscal 2027 net sales of $2.2 billion, up 5%, and GAAP net income per diluted share of $3.03, compared with a loss of $0.41 a year earlier. The company raised its full-year fiscal 2027 adjusted earnings per share guidance to $10.50 to $11.00 from $9.75 to $10.25, and its free cash flow outlook to $1.1 billion from $1.0 billion, with the adjusted EPS figures including tariff refunds received in the quarter.
Net sales were $2,219.3 million, up $106.0 million or 5% from $2,113.3 million a year earlier.
GAAP net income per diluted share was $3.03; adjusted EPS was $3.24, up 71% from $1.90, including an $0.84 benefit from tariff refunds.
Fiscal 2027 adjusted EPS guidance is $10.50 to $11.00, up from $9.75 to $10.25; net sales are now expected to decrease 1.0% to 2.0%, versus the prior decrease of 3.0% to 4.0%.
Free cash flow for the quarter was $337.3 million, compared with negative $94.9 million a year earlier.
Movado Group reported second-quarter fiscal 2027 net sales of $169.8 million, up 4.9% from a year earlier, and diluted earnings per share of $0.53 versus $0.13. The quarter includes $3.2 million in IEEPA duty refunds, worth $0.11 per diluted share, and the company has stopped providing an annual outlook, while declaring a $0.40 quarterly dividend.
Net sales were $169.8 million versus $161.8 million; U.S. and international sales each rose 4.9%.
Operating income was $14.9 million versus $4.0 million; adjusted operating income was $15.1 million, or 8.9% of net sales.
Diluted EPS was $0.53 versus $0.13; adjusted diluted EPS was $0.54 versus $0.23.
The company discontinued its annual outlook and expects second-half fiscal 2027 topline growth in the mid-single-digit range and gross margin of 55% to 56%, excluding additional IEEPA refunds.
Target Hospitality signed a new multi-year lease and services contract to support a data center in Pecos, West Texas, which the company expects to generate about $250 million of revenue through August 2030. The company also raised its full-year 2026 revenue and adjusted EBITDA outlook, with the midpoints up 6% and 22%, respectively, which points to higher expected revenue and earnings for shareholders.
Contract has an anticipated four-year term and is designed to accommodate about 1,100 individuals, with initial occupancy in August 2026 and full completion expected in September 2026.
2026 outlook: total revenue of $435 million to $445 million and adjusted EBITDA of $105 million to $115 million; total capital expenditures of $490 million to $510 million, excluding acquisitions.
The customer can terminate with no less than 60 days' advance notice if its prime contract ends, is suspended for an extended period, or is not performed.
At its virtual annual shareholder meeting, Kewaunee Scientific reported fiscal 2026 (ended April 30, 2026) revenue of $282.0 million, EBITDA of $22.4 million and net earnings of $9.6 million. Year-end backlog fell to $165.9 million from $214.6 million, which the company attributed mainly to completing several large international projects.
Fiscal 2026 revenue was $282.0 million; EBITDA was $22.4 million, up from $21.6 million in fiscal 2025.
Lab Products Group sales rose 19.8% to $214.9 million; International segment sales rose 9.9% to $67.1 million.
Consolidated backlog was $165.9 million at April 30, 2026, versus $214.6 million a year earlier.
Long-term debt was reduced by about $20 million, and debt-to-equity improved to 0.61-to-1.0 from 0.99-to-1.0.
Nuwellis furnished an updated corporate presentation dated August 25, 2026, under Regulation FD, for use in investor communications and conferences. The deck highlights 20% first-half 2026 revenue growth and a second-quarter 2026 gross margin of 76%, compared with 56% in the prior-year period, and says cash runway extends through the second quarter of 2027.
First-half 2026 revenue grew 20% over the prior-year period, per the presentation.
Second-quarter 2026 gross margin was 76%, versus 56% in the prior-year period.
The company says cash runway runs through the second quarter of 2027.
Company anticipates an FDA submission for the Aquadex pediatric label expansion by year-end 2026.
Donaldson reported record fourth-quarter fiscal 2026 sales of $1.1 billion, up 8.0%, and GAAP diluted EPS of $1.10, up 13.4%. For fiscal 2027 it forecasts sales growth of 5.5% to 9.5% and EPS of $4.22 to $4.38, compared with fiscal 2026 GAAP EPS of $3.85, reflecting dilution from the Facet acquisition.
Q4 fiscal 2026 sales $1,058.8 million, up 8.0%; GAAP diluted EPS $1.10 versus $0.97; adjusted EPS $1.15 versus $1.03
Full-year fiscal 2026 sales $3.9 billion, up 5.3%; GAAP EPS $3.85, up 26.2%; adjusted EPS $3.98, up 8.2%
Fiscal 2027 guidance: EPS $4.22 to $4.38, including about $0.12 of dilution from Facet; operating margin 16.6% to 17.2%
Full-year fiscal 2026 cash used in acquisitions was $822.6 million, and long-term debt rose to $1,280.0 million from $630.4 million
HEICO reported record third-quarter fiscal 2026 results for the three months ended July 31, 2026. Net income rose 33% to $235.4 million, or $1.67 per diluted share, from $1.26 a year earlier, while net sales rose 23% to a record $1,413.1 million. The company said it expects increased net sales at both segments for the rest of fiscal 2026, but the filing gives no numeric guidance.
Q3 net income $235.4 million, or $1.67 per diluted share, versus $1.26 in Q3 fiscal 2025
Q3 net sales $1,413.1 million, up 23%, including 14% consolidated organic growth
Operating margin improved to 25.1% from 23.1%; operating cash flow rose 49% to $345.3 million
Issued $550 million 4.950% senior notes due 2031 and $650 million 5.400% senior notes due 2036, using proceeds to repay revolver borrowings
On August 25, 2026, Huntsman stockholders voted to adopt the Merger Agreement with Olin Corporation, with 131,502,454 votes for and 1,828,828 against. The companies will implement the combination as a direct merger, and the transaction is expected to close in the first half of 2027, subject to regulatory approvals and other closing conditions.
Merger proposal: 131,502,454 for, 1,828,828 against, 378,859 abstentions
Advisory vote on merger-related executive pay: 117,592,172 for, 15,456,713 against, 661,256 abstentions
Quorum of 133,710,141 votes, or 76.23% of the 175,381,417 shares entitled to vote as of the July 9, 2026 record date
Expected closing in the first half of 2027, subject to required regulatory approvals
nCino reported second-quarter fiscal 2027 results for the period ended July 31, 2026, with total revenues up 8% and GAAP operating income of $13.6 million, compared with a $9.3 million loss a year earlier. The board also authorized an additional $100 million stock repurchase program, and the company issued revenue and profit guidance for the third quarter and fiscal 2027.
Total revenues were $161.0 million, up 8% from $148.8 million; subscription revenues were $143.5 million, up 10%.
GAAP income from operations was $13.6 million versus a $9.3 million loss in the prior-year quarter; non-GAAP operating income was $40.8 million, up 36%.
The board authorized a new repurchase program of up to $100 million of common stock, following $300 million in repurchases since April 2025.
Third-quarter total revenues are guided to $161.25 million to $163.25 million; fiscal 2027 total revenues are guided to $644.0 million to $647.0 million.
Box reported second-quarter fiscal 2027 revenue of $321.1 million, up 9% from a year earlier, with GAAP diluted earnings per share of $0.09 versus $0.05 and non-GAAP diluted EPS of $0.40 versus $0.33. The company guided to third-quarter revenue of about $329 million and full-year fiscal 2027 non-GAAP EPS of about $1.54, and it repurchased 2.6 million shares for about $66 million in the quarter.
Revenue of $321.1 million, up 9%, or 11% in constant currency
GAAP diluted EPS of $0.09 vs. $0.05; non-GAAP diluted EPS of $0.40 vs. $0.33
Q3 fiscal 2027 revenue guidance of about $329 million; full-year revenue guidance of about $1.290 billion
Repurchased 2.6 million shares for about $66 million; about $378 million of buyback capacity remained as of July 31, 2026
Semtech reported second-quarter fiscal 2027 results for the quarter ended July 26, 2026, with net sales of $341.9 million, up 33% from a year earlier and up 17% from the prior quarter. GAAP net income was $160.1 million, which included a $101.4 million income tax benefit, compared with a net loss of $27.1 million a year earlier. The company also guided third-quarter net sales to $410.0 million plus or minus $5.0 million and adjusted diluted EPS to $1.05 plus or minus $0.03.
Net sales of $341.9 million, up from $257.6 million in Q2 FY2026 and $291.0 million in Q1 FY2027.
GAAP diluted EPS of $1.59, compared with a loss of $0.31 a year earlier; the quarter included a $101.4 million tax benefit.
Non-GAAP adjusted diluted EPS of $0.71, up from $0.41 in Q2 FY2026.
Q3 FY2027 outlook: net sales of $410.0 million plus or minus $5.0 million; adjusted diluted EPS of $1.05 plus or minus $0.03.
Zoom reported fiscal second-quarter 2027 results for the three months ended July 31, 2026. Revenue rose 4.9% to $1,277.2 million and non-GAAP diluted earnings per share rose to $1.55 from $1.53, while GAAP diluted EPS reached $5.15 mainly because of $1,614.2 million in gains on strategic investments. The company also updated its full fiscal 2027 outlook, which now calls for total revenue of $5.085 billion to $5.095 billion.
Total revenue $1,277.2 million, up 4.9%; Enterprise revenue $787.5 million, up 7.8%
GAAP net income $1,542.4 million ($5.15 per diluted share), versus $358.6 million ($1.16) a year earlier
GAAP income from operations $314.3 million, down from $321.7 million; free cash flow $472.4 million, down from $508.0 million
Full fiscal 2027 guidance: revenue $5.085 billion to $5.095 billion; non-GAAP diluted EPS $6.08 to $6.12
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.